Company Overview and News

 
Orinoco Gold continues to advance Cascavel gold mine recommissioning

2018-04-18 proactiveinvestors.com.au
Orinoco Gold Ltd (ASX:OGX) is continuing to make steady progress on recommissioning operations at its Cascavel Mine, a core asset within its Faina Goldfields Project in Brazil.

 
Orinoco raises $12m

2018-03-23 businessnews.com.au
Junior miner Orinoco Gold has announced a $12.1 million capital raising to target a ramp up in production at its Cascavel operation in Brazil.

 
Amzalak closes in on leader Ellis as Jatenergy goes gangbusters

2018-03-23 smh.com.au
Mendy Amzalak of AMZ Capital has narrowed the gap with race leader Angie Ellis of 80 20 Investments, in week three of the four-week shares race.

 
Ellis maintains lead as Smart Park fires up

2018-03-17 smh.com.au
Angie Ellis of 80 20 Investments has maintained her lead over her closest rival, Mendy Amzalak of AMZ Capital, in week two of the four-week shares race with her original $100,000 portfolio worth $114,584.

 
Tyranna Resources director supports gold strategy through off-market purchase

2018-02-15 proactiveinvestors.com.au
Tyranna Resources Ltd (ASX:TYX) non-executive director Joseph Pinto has demonstrated his confidence in the company’s gold strategy by increasing his indirect interest.

 
Tyranna Resources gets busy as it progresses gold strategy

2018-02-04 proactiveinvestors.com.au
Tyranna Resources Ltd (ASX:TYX) has set the scene for a busy 2018 work program across its portfolio of gold projects while its gold investments are increasing in value.

 
Local gold stocks up

2018-01-12 businessnews.com.au
Shares in Orinoco Gold and Doray Minerals have enjoyed price rises today after announcing positive drilling results at their respective projects.

 
Orinoco Gold hits a 45g/t average at Brazilian operation

2018-01-11 australianmining.com.au
Orinoco has cited the benefits of its back-to-basics approach to milling at its Cascavel gold mine in Brazil, returning six samples from its pilot hammer mill with an average grade of 36.68 grams per tonne (g/t) of gold.

 
CIO Agrees AUD$3.2 Million Sale of Eureka Gold Project

2017-12-01 marketwired
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO UNITED STATES SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

 
Tyranna Resources’ drilling to target Challenger-type gold in South Australia

2017-11-27 proactiveinvestors.com.au
Tyranna Resources Ltd (ASX:TYX) is commencing a diamond drilling program at the Greenwood Gold Prospect, part of the larger Jumbuck Gold Project in South Australia.

 
Tyranna Resources shares surge as conglomerate gold rush continues

2017-11-08 proactiveinvestors.com.au
Tyranna Resources Ltd (ASX:TYX) continues to benefit from investor demand for companies exploring for conglomerate-hosted gold in the Pilbara region of Western Australia.

 
Orinoco Gold Ltd shares rise on achieving progress at Cascavel Gold Mine

2017-07-11 proactiveinvestors.com.au
Orinoco Gold Ltd (ASX:OGX) shares closed 31% higher today after continuing to make significant progress on its plan to re-commence operations at the Cascavel Gold Mine in Brazil.

 
Nuheara, Kangaroo Resources, Orinoco Gold - ASX major movers

2017-07-11 proactiveinvestors.com.au
Nuheara Ltd (ASX:NUH) rose 4% to $0.096 after American retailer Brookstone said it would stock the company’s breakthrough earbuds in a further 150 stores. This means the product, which includes dynamic noise control and speech amplification, is available in 201 outlets. Chief executive Justin Miller said the expansion of the existing agreement underscored the “vast sales potential” of its IQbuds brand.

 
Orinoco Gold confirms Craig Dawson will take the helm

2017-05-30 proactiveinvestors.com.au
Orinoco Gold (ASX:OGX) has now confirmed the appointment of Craig Dawson as the company's chief executive officer, effective from 1 June 2017.

 
Orinoco buys out JV partners as MD and chair resign

2017-04-27 businessnews.com.au
Perth explorer Orinoco Gold has announced plans to buy out its joint venture partners at the Cascavel mine for $US6.3 million in cash and shares, while both its managing director and chairman have tendered their resignation.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...